195 related articles for article (PubMed ID: 29101337)
1. Trichostatin A ameliorates renal tubulointerstitial fibrosis through modulation of the JNK-dependent Notch-2 signaling pathway.
Tung CW; Hsu YC; Cai CJ; Shih YH; Wang CJ; Chang PJ; Lin CL
Sci Rep; 2017 Nov; 7(1):14495. PubMed ID: 29101337
[TBL] [Abstract][Full Text] [Related]
2. HuangQi Decoction Ameliorates Renal Fibrosis via TGF-β/Smad Signaling Pathway In Vivo and In Vitro.
Zhao J; Wang L; Cao AL; Jiang MQ; Chen X; Wang Y; Wang YM; Wang H; Zhang XM; Peng W
Cell Physiol Biochem; 2016; 38(5):1761-74. PubMed ID: 27161221
[TBL] [Abstract][Full Text] [Related]
3. Identification of histone deacetylase 8 as a novel therapeutic target for renal fibrosis.
Zhang Y; Zou J; Tolbert E; Zhao TC; Bayliss G; Zhuang S
FASEB J; 2020 Jun; 34(6):7295-7310. PubMed ID: 32281211
[TBL] [Abstract][Full Text] [Related]
4. Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling.
Liu N; He S; Ma L; Ponnusamy M; Tang J; Tolbert E; Bayliss G; Zhao TC; Yan H; Zhuang S
PLoS One; 2013; 8(1):e54001. PubMed ID: 23342059
[TBL] [Abstract][Full Text] [Related]
5. Anti-renal fibrosis effect of asperulosidic acid via TGF-β1/smad2/smad3 and NF-κB signaling pathways in a rat model of unilateral ureteral obstruction.
Xianyuan L; Wei Z; Yaqian D; Dan Z; Xueli T; Zhanglu D; Guanyi L; Lan T; Menghua L
Phytomedicine; 2019 Feb; 53():274-285. PubMed ID: 30668407
[TBL] [Abstract][Full Text] [Related]
6. Tamoxifen ameliorates renal tubulointerstitial fibrosis by modulation of estrogen receptor α-mediated transforming growth factor-β1/Smad signaling pathway.
Kim D; Lee AS; Jung YJ; Yang KH; Lee S; Park SK; Kim W; Kang KP
Nephrol Dial Transplant; 2014 Nov; 29(11):2043-53. PubMed ID: 25031017
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-17A induces renal fibrosis through the ERK and Smad signaling pathways.
Weng CH; Li YJ; Wu HH; Liu SH; Hsu HH; Chen YC; Yang CW; Chu PH; Tian YC
Biomed Pharmacother; 2020 Mar; 123():109741. PubMed ID: 31901549
[TBL] [Abstract][Full Text] [Related]
8. TGF-β1 receptor blockade attenuates unilateral ureteral obstruction-induced renal fibrosis in C57BL/6 mice through attenuating Smad and MAPK pathways.
Nazari Soltan Ahmad S; Kalantary-Charvadeh A; Hamzavi M; Ezzatifar F; Aboutalebi Vand Beilankouhi E; Toofani-Milani A; Geravand F; Golshadi Z; Mesgari-Abbasi M
J Mol Histol; 2022 Aug; 53(4):691-698. PubMed ID: 35704228
[TBL] [Abstract][Full Text] [Related]
9. You-gui Pill ameliorates renal tubulointerstitial fibrosis via inhibition of TGF-β/Smad signaling pathway.
Wang L; Cao AL; Chi YF; Ju ZC; Yin PH; Zhang XM; Peng W
J Ethnopharmacol; 2015 Jul; 169():229-38. PubMed ID: 25922264
[TBL] [Abstract][Full Text] [Related]
10. Low-dose paclitaxel ameliorates renal fibrosis by suppressing transforming growth factor-β1-induced plasminogen activator inhibitor-1 signaling.
Jung ES; Lee J; Heo NJ; Kim S; Kim DK; Joo KW; Han JS
Nephrology (Carlton); 2016 Jul; 21(7):574-82. PubMed ID: 26869361
[TBL] [Abstract][Full Text] [Related]
11. TGF-β1 → SMAD/p53/USF2 → PAI-1 transcriptional axis in ureteral obstruction-induced renal fibrosis.
Samarakoon R; Overstreet JM; Higgins SP; Higgins PJ
Cell Tissue Res; 2012 Jan; 347(1):117-28. PubMed ID: 21638209
[TBL] [Abstract][Full Text] [Related]
12. Fluorofenidone attenuates tubulointerstitial fibrosis by inhibiting TGF-β(1)-induced fibroblast activation.
Yuan Q; Wang R; Peng Y; Fu X; Wang W; Wang L; Zhang F; Peng Z; Ning W; Hu G; Wang Z; Tao L
Am J Nephrol; 2011; 34(2):181-94. PubMed ID: 21791914
[TBL] [Abstract][Full Text] [Related]
13. Ganoderic acid hinders renal fibrosis via suppressing the TGF-β/Smad and MAPK signaling pathways.
Geng XQ; Ma A; He JZ; Wang L; Jia YL; Shao GY; Li M; Zhou H; Lin SQ; Ran JH; Yang BX
Acta Pharmacol Sin; 2020 May; 41(5):670-677. PubMed ID: 31804606
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase 6 inhibition mitigates renal fibrosis by suppressing TGF-β and EGFR signaling pathways in obstructive nephropathy.
Chen X; Yu C; Hou X; Li J; Li T; Qiu A; Liu N; Zhuang S
Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1003-F1014. PubMed ID: 33103445
[TBL] [Abstract][Full Text] [Related]
15. HDAC dependent transcriptional repression of Bmp-7 potentiates TGF-β mediated renal fibrosis in obstructive uropathy.
Manson SR; Song JB; Hruska KA; Austin PF
J Urol; 2014 Jan; 191(1):242-52. PubMed ID: 23820056
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy.
Pang M; Kothapally J; Mao H; Tolbert E; Ponnusamy M; Chin YE; Zhuang S
Am J Physiol Renal Physiol; 2009 Oct; 297(4):F996-F1005. PubMed ID: 19640900
[TBL] [Abstract][Full Text] [Related]
17. Endothelial dysfunction exacerbates renal interstitial fibrosis through enhancing fibroblast Smad3 linker phosphorylation in the mouse obstructed kidney.
Sun YB; Qu X; Li X; Nikolic-Paterson DJ; Li J
PLoS One; 2013; 8(12):e84063. PubMed ID: 24391884
[TBL] [Abstract][Full Text] [Related]
18. The Notch γ-secretase inhibitor ameliorates kidney fibrosis via inhibition of TGF-β/Smad2/3 signaling pathway activation.
Xiao Z; Zhang J; Peng X; Dong Y; Jia L; Li H; Du J
Int J Biochem Cell Biol; 2014 Oct; 55():65-71. PubMed ID: 25150830
[TBL] [Abstract][Full Text] [Related]
19. Valproic acid attenuates renal fibrosis through the induction of autophagy.
Kawaoka K; Doi S; Nakashima A; Yamada K; Ueno T; Doi T; Masaki T
Clin Exp Nephrol; 2017 Oct; 21(5):771-780. PubMed ID: 27928635
[TBL] [Abstract][Full Text] [Related]
20. Baicalin ameliorates renal fibrosis via inhibition of transforming growth factor β1 production and downstream signal transduction.
Zheng L; Zhang C; Li L; Hu C; Hu M; Sidikejiang N; Wang X; Lin M; Rong R
Mol Med Rep; 2017 Apr; 15(4):1702-1712. PubMed ID: 28260014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
